Patent · US Active

Hepatitis C virus inhibitors

US8044087B2 · kind B2 · utility

1Cited by

13References

17Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Alan Xiangdong Wang · Guilford, US
Ramkumar Rajamani · Wallingford, US
Paul Michael Scola · Glastonbury, US

Key dates

Filing date	Sep 24, 2009
Grant date	Oct 25, 2011
Priority date	—
Expiry date	Feb 10, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/081
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Hepatitis C virus inhibitors having the general formulaare disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.